Nach der Markteinführung der so genannten „atypischen” Neuroleptika ist mehrfach über
erhöhte Blutzuckerwerte und auch über einen Diabetes mellitus Typ II bei Patienten, die mit …

Hyperglycaemia is known occasionally to occur with conventional neuroleptics, but has
more recently been associated with atypical antipsychotics especially clozapine and …

Aims Atypical anti‐psychotic drugs (APDs) are widely used in psychotic disorders refractory
to conventional neuroleptic agents. Results Three cases of new‐onset diabetes are reported …

Recently there has been increased concern over the side effects of the atypical antipsychotic
drugs, including diabetes, hyperlipidemia and obesity. The relationship between diabetes …

There have been recent reports in the psychiatric literature of the possible association of
glucose dysregulation and diabetes mellitus with the use of atypical antipsychotics. This …

Atypical antipsychotics offer significant improvements over older, conventional antipsychotic
agents. However, recently the newer agents have been linked to medical morbidity including …

As a class, the atypical antipsychotics are the first line treatment choice for the
psychopharmacologic management of psychotic disorders. Emerging evidence currently …

During the last few years, concern has risen about a potential diabetes mellitus DM)-
inducing effect of some atypical antipsychotics, especially clozapine and olanzapine …

Even if some metabolic disorders had previously been identified among patients with
schizophrenia, it is with the birth of anti-psychotics starting in the 1950s that those disorders …

Recently, there has been increased concern about the occurrence of diabetes associated
with the use of atypical antipsychotic (AAP) drugs. The relationship between diabetes …